MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK.
MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK; South East Scotland Clinical Genetics Service, Western General Hospital, Edinburgh EH4 2XU, UK.
Am J Hum Genet. 2018 Dec 6;103(6):1038-1044. doi: 10.1016/j.ajhg.2018.10.024. Epub 2018 Nov 29.
During genome replication, polymerase epsilon (Pol ε) acts as the major leading-strand DNA polymerase. Here we report the identification of biallelic mutations in POLE, encoding the Pol ε catalytic subunit POLE1, in 15 individuals from 12 families. Phenotypically, these individuals had clinical features closely resembling IMAGe syndrome (intrauterine growth restriction [IUGR], metaphyseal dysplasia, adrenal hypoplasia congenita, and genitourinary anomalies in males), a disorder previously associated with gain-of-function mutations in CDKN1C. POLE1-deficient individuals also exhibited distinctive facial features and variable immune dysfunction with evidence of lymphocyte deficiency. All subjects shared the same intronic variant (c.1686+32C>G) as part of a common haplotype, in combination with different loss-of-function variants in trans. The intronic variant alters splicing, and together the biallelic mutations lead to cellular deficiency of Pol ε and delayed S-phase progression. In summary, we establish POLE as a second gene in which mutations cause IMAGe syndrome. These findings add to a growing list of disorders due to mutations in DNA replication genes that manifest growth restriction alongside adrenal dysfunction and/or immunodeficiency, consolidating these as replisome phenotypes and highlighting a need for future studies to understand the tissue-specific development roles of the encoded proteins.
在基因组复制过程中,聚合酶 ε(Pol ε)作为主要的前导链 DNA 聚合酶发挥作用。在这里,我们报告了在 12 个家庭的 15 个人中发现了编码 Pol ε 催化亚基 POLE1 的 POLE 基因的双等位基因突变。表型上,这些个体具有与 IMAGe 综合征(宫内生长受限[IUGR]、干骺端发育不良、先天性肾上腺发育不全和男性泌尿生殖系统异常)非常相似的临床特征,这是一种先前与 CDKN1C 功能获得性突变相关的疾病。POLE1 缺陷个体还表现出独特的面部特征和可变的免疫功能障碍,伴有淋巴细胞缺乏的证据。所有受试者均携带相同的内含子变异(c.1686+32C>G),作为常见单倍型的一部分,与不同的反式失活变异相结合。内含子变异改变剪接,双等位基因突变导致 Pol ε 细胞缺乏和 S 期进展延迟。总之,我们确定 POLE 是导致 IMAGe 综合征的第二个基因突变的基因。这些发现增加了由于 DNA 复制基因突变导致的越来越多的疾病,这些疾病表现为生长受限以及肾上腺功能障碍和/或免疫缺陷,将这些疾病作为复制体表型进行整合,并强调需要未来的研究来了解编码蛋白的组织特异性发育作用。